findmyKOL

Daniel Fontenot, MD

Basic profile

Federal Bureau of Investigation

ORCIDNone on fileNPI↗
✓ Full record
RegionBaton Rouge, LA · South CentralSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Daniel Fontenot is a Cardiology physician affiliated with Federal Bureau of Investigation. OpenAlex indexes 6 publications with 377 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

377citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
34companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5231 Brittany Dr
Baton Rouge, LA 708089100

Telephone

225-769-0933

Provider last certified this registry record 31 Mar 2026.

View the NPPES registry record

Industry payments

34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.5%
    Beta blocker20.3%
    Metoprolol Succinate30%Carvedilol28%Metoprolol Tartrate17%Sotalol13%Nebivolol Hcl9%Acebutolol Hcl3%Atenolol1%Sotalol Af1%
    Part D<11 patients
    Statin11.3%
    Rosuvastatin Calcium47%Atorvastatin Calcium42%Simvastatin7%Pravastatin Sodium4%
    Part D<11 patients

    + 23 more classes in this area

  • Blood & clotting

    13.7%
    Factor Xa inhibitor9.5%
    Eliquis98%Xarelto2%
    Part D<11 patients
    P2Y12 inhibitor3.9%
    Clopidogrel89%Brilinta8%Prasugrel Hcl3%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3%
    Potassium supplement1.5%
    Potassium Chloride93%Klor-Con M208%
    Part D<11 patients
    SGLT2 inhibitor1.4%
    Farxiga100%
    Part D≥22 patients

    + 1 more class in this area

Where care is delivered (Part B)1% facility · 99% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”